Biosight Ltd and Advaxis Inc to Discuss Proposed Transaction Call Transcript
Greetings, and welcome to the Advaxis and Biosight merger announcement. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Mr. Tim McCarthy with LifeSci Advisors. Thank you. You may begin.
Thank you, Melissa. Good morning. Joining me on today's call are Ken Berlin, President and CEO and Interim Chief Financial Officer of Advaxis; Andres Gutierrez; EVP and Chief Medical Officer of Advaxis; Dr. Ruth Ben Yakar, CEO of Biosight; Roy Golan, EVP and Chief Financial Officer of Biosight; and Darrel Cohen, Chief Medical Officer of Biosight. A replay of today's call will be available on the Investors section of the Advaxis' website and the [new site] for 90 days.
Before proceeding, we'd like to remind participants that during the course of this call, representatives of Advaxis or Biosight may provide information that contains forward-looking statements. These statements are based on assumptions that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
